Actively Recruiting
A Study of IBI3032 in Healthy Participants
Led by Fortvita Biologics (USA)Inc. · Updated on 2025-09-17
32
Participants Needed
1
Research Sites
9 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a randomized, double-blind, placebo-controlled Phase I clinical study evaluating the safety, tolerability, and PK of a single dose of IBI3032 in healthy participants. This is a single ascending dose (SAD) study. Approximately 32 healthy participants are expected to be enrolled in this study. The screening period is 4 weeks. Eligible participants will be divided into 4 cohorts. Each cohort consisted of 8 healthy participants who will be randomized in a 6:2 ratio to receive a single dose of IBI3032 or placebo. The safety follow-up period is 15 days. This study is for research purposes only, and is not intended to treat any medical condition.
CONDITIONS
Official Title
A Study of IBI3032 in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy males or females based on medical history
- Safety laboratory results within normal reference ranges
You will not qualify if you...
- Known allergies to IBI3032, glucagon-like peptide-1 (GLP-1) analogs, or related compounds
- Abnormal electrocardiogram (ECG) at screening
- Significant history or current condition of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, or neurological disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ICON Clinical Research
Lenexa, Kansas, United States, 66219
Actively Recruiting
Research Team
L
lily Zhang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
OTHER
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here